CAXTON CORP

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1388551 Princeton, NJ

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$78,958

-$1,074 QoQ

Shares Held

16,962

+21.7% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

4.87%

of 13F equity value

Holder Rank

#89

of 142 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CAXTON CORP holds $362,737 across 5 Biotechnology names. LXEO ranks #2 (21.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYTX	Kyverna Therapeutics, Inc.	12,347	$110,011
2	LXEO	Lexeo Therapeutics, Inc. This page	16,962	$78,958
3	XFOR	X4 Pharmaceuticals, Inc	15,557	$72,651
4	IKT	Inhibikase Therapeutics, Inc.	28,453	$57,759
5	ALXO	Alx Oncology Holdings Inc	20,946	$43,358

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$78,958	16,962	+21.7%	Shares	Sole	2026-08-14
2026-03-31	$80,032	13,943	0.0%	Shares	Sole	2026-05-14
2025-12-31	$138,453	13,943	-19.6%	Shares	Sole	2026-02-13
2025-09-30	$115,084	17,332	0.0%	Shares	Sole	2025-11-14
2025-06-30	$69,674	17,332	-2.9%	Shares	Sole	2025-08-14
2025-03-31	$61,942	17,851	0.0%	Shares	Sole	2025-05-15
2024-12-31	$117,459	17,851	0.0%	Shares	Sole	2025-02-14
2024-09-30	$161,373	17,851	0.0%	Shares	Sole	2024-11-14
2024-06-30	$286,330	17,851	+73.0%	Shares	Sole	2024-08-14
2024-03-31	$161,801	10,319	0.0%	Shares	Sole	2024-05-15
2023-12-31	$138,480	10,319	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.